Chemical activators of the Glial cell line-derived neurotrophic factor receptor 1 (GFR-1) engage in various biochemical pathways to enhance receptor signaling. (S)-3,5-DHPG, a group I metabotropic glutamate receptor agonist, initiates a cascade that can result in increased intracellular calcium levels. This rise in calcium can positively influence the activity of the RET coreceptor that associates with GFR-1, amplifying the signal. Similarly, Mangiferin and IBMX elevate cAMP levels, which leads to the activation of protein kinase A (PKA). PKA, in turn, can phosphorylate RET, resulting in enhanced GFR-1-mediated signaling. Forskolin, like Mangiferin and IBMX, also increases cAMP and subsequently activates PKA, contributing to the phosphorylation and activation of RET. This series of events can amplify GFR-1 signaling.
Other chemicals like Anisomycin and Beta-Lapachone function through different mechanisms but converge on the same pathway. Anisomycin activates the JNK pathway, which can lead to the upregulation of RET phosphorylation and, consequently, GFR-1 activity. Beta-Lapachone operates through modulating cellular redox states and thus can indirectly influence the activity of tyrosine kinases such as RET, promoting GFR-1 signaling. Zinc pyrithione raises intracellular zinc levels, which can enhance kinase activity involved in RET phosphorylation and GFR-1 signaling. Sodium orthovanadate and Cantharidin inhibit protein phosphatases, leading to increased phosphorylation of RET, thereby facilitating GFR-1 activation. Genistein, while primarily known as a tyrosine kinase inhibitor, at certain concentrations can enhance RET phosphorylation and GFR-1 activity. Similarly, Quercetin modulates kinase signaling pathways, which can contribute to increased RET activity and subsequent GFR-1 signaling enhancement.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-3,5-DHPG | 162870-29-3 | sc-204256 sc-204256A | 5 mg 10 mg | $210.00 $353.00 | 2 | |
(S)-3,5-DHPG selectively activates group I metabotropic glutamate receptors, which could lead to an increase in intracellular calcium levels. Elevated calcium may enhance the activity of RET, the coreceptor associated with GFR-1, thereby potentiating GFR-1 signaling. | ||||||
Mangiferin | 4773-96-0 | sc-491041 | 10 mg | $140.00 | ||
Mangiferin increases cAMP levels, which can lead to the activation of PKA. PKA can phosphorylate and activate the RET receptor that complexes with GFR-1, leading to enhanced GFR-1-mediated signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX increases intracellular cAMP by inhibiting phosphodiesterases, which may lead to PKA activation. PKA can then phosphorylate and activate RET that associates with GFR-1, thus augmenting GFR-1 signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK pathway, which is known to interact with RET signaling. Activation of JNK could enhance RET phosphorylation and thus indirectly increase GFR-1 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases that can increase phosphorylation levels of tyrosine kinases like RET, which when associated with GFR-1, can lead to its activation. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
Beta-Lapachone activates NQO1, which modulates cellular redox states. Redox changes can activate tyrosine kinases such as RET that are associated with GFR-1, leading to GFR-1 signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc pyrithione can lead to increased intracellular zinc levels, which may enhance kinase activity involved in RET phosphorylation, thereby promoting GFR-1 activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor but at certain concentrations can paradoxically enhance tyrosine kinase activity. This could lead to increased RET activity and, as a result, GFR-1 activation. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases, potentially leading to increased phosphorylation and activation of RET, which in turn would enhance GFR-1 signaling. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, is known to modulate kinase signaling pathways. It could enhance the phosphorylation status of RET, thereby potentiating GFR-1 activity. | ||||||